Updates To Safety Labelling For Benzodiazepines And Benzodiazepine-like Drugs

Recall Summary Health Canada is updating safety labels on benzodiazepines and benzodiazepine-like drugs (medications used to treat anxiety, insomnia, and seizures) to include new warnings about risks. The update affects all benzodiazepine products distributed across Canada. This is a labeling change to inform patients and healthcare providers of additional safety information about these medications.

Category

consumer product recall

Country

Canada

Agency

HC-PRODUCTS

Recall date

2020-10-30

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/7349000d-d576-4764-8ac4-ca90b6120752